Breast Cancer Clinical Trials in Raleigh, NC

Breast Cancer Clinical Trials in Raleigh, NC

View the best 10 breast cancer medical studies in Raleigh, North Carolina. Access promising new therapies by applying to a Raleigh-based Breast Cancer clinical trial.

Trials in Raleigh, North Carolina

Here are the top 10 medical studies for breast cancer in Raleigh, North Carolina

Image of UNC Lineberger Comprehensive Cancer Center in Chapel Hill, United States.

Intrinsic Subtyping of Primary Breast Cancer

Recruiting1 award11 criteria
This trial is testing whether giving doctors information about the molecular subtype of a patient's metastatic breast cancer will help them choose more effective treatments.
Image of The Oncology Institute of Hope & Innovation in Anaheim, United States.

Trastuzumab Emtansine (T-DM1) +1 More

Monoclonal Antibodies

Recruiting2 awardsPhase 3
This trial will compare the effectiveness of two drugs for treating breast cancer that has come back after initial treatment.
Image of CBCC Global Research Inc., at Comprehensive Blood and Cancer Center in Bakersfield, United States.

Endocrine Therapy of Physician's Choice +1 More

Hormone Therapy

Recruiting2 awardsPhase 3
This trial is testing giredestrant, a medication given after initial treatment to prevent breast cancer from returning. It focuses on patients with a specific type of early-stage breast cancer that is hormone-driven and at higher risk of recurrence. Giredestrant works by blocking the hormone estrogen from helping cancer cells grow. Giredestrant has shown promise in previous studies.
Image of City of Hope Comprehensive Cancer Center in Duarte, United States.

T-DM1

Antibody-Drug Conjugate

Recruiting1 awardPhase 2
This trial is studying T-DM1 to see how well it works compared to standard treatment in treating patients with HER2-positive breast cancer.
Image of University of South Alabama - Mitchell Cancer Institute in Mobile, United States.

T-DM1 +1 More

Antibody Drug Conjugate

Recruiting1 awardPhase 3
This trial is being done to see if adding tucatinib to T-DM1 helps patients with HER2 positive breast carcinoma.
Image of University of Alabama at Birmingham in Birmingham, United States.

Stereotactic Radiosurgery +1 More

Radiation

Recruiting1 awardPhase 1 & 2
This trial is testing a combination of focused radiation, olaparib, and immunotherapy for patients with specific types of breast cancer that have spread to the brain. The treatment aims to kill cancer cells, make them more vulnerable, and boost the body's immune response. Olaparib has shown promising results in various cancers.
Image of UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, United States.

9-ING-41

GSK-3β inhibitor

Recruiting1 awardPhase 2
This trial is testing a new drug to see if it is safe and effective in treating cancer. The drug is designed to target a protein called GSK-3β, which is found in many different types of cancer cells.
Image of University of Alabama at Birmingham in Birmingham, United States.

Olaparib

PARP Inhibitor

Recruiting1 awardPhase 2
This trial is for patients with metastatic breast cancer who have an altered gene that suggests the tumor may not be able to repair its genetic material. The study will evaluate whether the drug Olaparib is effective in treating the cancer.
Image of University of North Carolina at Chapel Hill in Chapel Hill, United States.

Engagement in Physical Activity

Recruiting1 award8 criteria
This trial is testing whether being physically active during chemotherapy can help moderate increases in p16 levels. 100 patients with breast cancer will be recruited and monitored throughout their chemotherapy treatment.
Image of UT Southwestern Medical Center in Dallas, United States.

CDX-301 +2 More

Flt3 Ligand

Recruiting1 awardPhase 1
This trial tests a new combination of two immune-boosting drugs and a chemotherapy drug in patients with hard-to-treat breast cancer. The goal is to see if this combination is safe and effective at controlling the cancer.

Phase 3 Trials

Trials With No Placebo

View More Related Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.